Neurodiversity, ADHD, Autism, and AuDHD
The Science Behind Finding the Optimal ADHD Medication Dose (Psychologytoday)
Summary: A systematic review of 113 ADHD medication trials published in The Lancet Psychiatry identifies optimal dosing ranges for methylphenidate, amphetamines, guanfacine, and others. The study confirms a ceiling effect: beyond certain thresholds, symptom improvement plateaus while side effects rise. For youth, the greatest average benefit was at 45 mg/day for methylphenidate and 25 mg/day for amphetamines; for adults, amphetamines plateaued around 50 mg/day. The review underscores that titration should aim for the lowest effective dose, but it could not assess developmental differences within the under-18 group or variations by race or gender.
Why it matters: This provides clinicians and patients with evidence-based dose ceilings to avoid overmedication, a common cause of discontinuation, while reinforcing the need for individualized titration—especially given that group averages cannot predict personal response.
Context: ADHD medication dosing has long relied on trial and error; this meta-analysis aggregates data from over 25,000 participants to establish population-level optimal ranges, though it leaves gaps in pediatric subpopulations and demographic diversity.
"For children and adolescents, the greatest average benefit was estimated at approximately 45 mg/day for methylphenidate, 25 mg/day for amphetamine-based medications, and 4 mg/day for guanfacine. On average, increasing doses beyond these levels did not provide additional symptom improvement; instead, side effects became more common." — PSYCHOLOGYTODAY
Commentary: The study’s inability to parse age-related differences within the 5–18 range is a significant limitation, given that metabolic rates and body mass vary widely across that span. Clinicians should treat these averages as guardrails, not targets, and remain alert to the fact that comorbidities like autism or mood disorders can shift optimal dosing. The real takeaway is structural: the field now has a clearer signal that more drug is not better, which should reduce the reflex to escalate doses when initial response is modest.
Date: July 15, 2026 02:19 PM ET
URL: https://psychologytoday.com/nz/blog/preparing-for-parenthood/202607/the-science-behind-finding-the-optimal-adhd-medication-dose
AI Sentiment Score: Negative (81%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.The Changing Face of Autism (Psychologytoday)
Summary: Two foundational models of autism—the ‘extreme male brain’ theory and the broad spectrum concept—are being formally retired or challenged by their original proponents, Simon Baron-Cohen and Uta Frith. Baron-Cohen now says the ‘extreme male brain’ language is unhelpful and reinforces stereotypes, though he maintains the underlying science. Frith argues the spectrum has widened to the ‘point of collapse,’ blurring distinctions between profound autism and later-emerging conditions like anxiety. These revisions leave many autistic individuals and clinicians grappling with a suddenly unstable diagnostic and self-understanding framework.
Why it matters: For a community that has built identity, advocacy, and clinical practice around these models, their retraction creates immediate uncertainty about diagnosis, support allocation, and self-concept—with real consequences for policy, funding, and daily life.
Context: Both models have been influential for decades: Baron-Cohen’s theory shaped research on cognitive sex differences and autism etiology, while Frith’s spectrum concept underpins the current broad diagnostic criteria in the DSM and ICD.
"The autism spectrum has widened to the ‘point of collapse’ so that a diagnosis itself does not give a picture of key characteristics or point to appropriate support." — PSYCHOLOGYTODAY
Commentary: The retirements are less a clean scientific correction than a belated acknowledgment of long-standing critiques from feminist and autistic scholars. Baron-Cohen’s refusal to disavow the underlying science leaves the gender-stereotype enforcement intact, while Frith’s proposal to carve out ‘profound autism’ risks creating a two-tier system that could marginalize higher-masking individuals. The real test will be whether new models emerge that are both empirically robust and clinically useful—or whether the field fragments into competing frameworks that confuse rather than clarify.
Date: July 15, 2026 11:40 AM ET
URL: https://psychologytoday.com/sg/blog/domestic-intelligence/202607/the-changing-face-of-autism
AI Sentiment Score: Positive (50%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.Medicaid Work Requirements: Learn More and Take Action! (Autisticadvocacy)
Summary: Links to Parts of This Resource: Click on each link to jump to that part of the resource. – What is this resource? – What is the new rule about?
Why it matters: This matters for Neurodiversity, ADHD, Autism, and AuDHD because it gives a concrete current signal to track: Links to Parts of This Resource: Click on each link to jump to that part of the resource.
Context: Links to Parts of This Resource: Click on each link to jump to that part of the resource. – What is this resource? – What is the new rule about?
"Links to Parts of This Resource: Click on each link to jump to that part of the resource. – What is this resource? – What is the new rule about? – What." — AUTISTICADVOCACY
Commentary: The immediate implication is operational rather than speculative: watch how this changes budgets, workflows, or risk assumptions over the next cycle.
Date: July 13, 2026 01:05 PM ET
URL: https://autisticadvocacy.org/2026/07/medicaid-work-requirements-learn-more-and-take-action/
AI Sentiment Score: Positive (66%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.Capitol Connection: July 16, 2026 | Autism Society (Autismsociety)
Summary: The Autism Society of America’s July 2026 Capitol Connection reports the Department of Education’s proposed Interagency Agreements would move special education and civil rights functions to HHS and DOJ, respectively, raising concerns about fragmented oversight. The DOJ’s Office of Legal Counsel issued a memo stating the ADA does not require states to provide services in the most integrated setting, challenging the Olmstead precedent. A new education guide from the Autism Society and AFT aims to support inclusive classrooms. Medicaid work requirements face a multi-state lawsuit over restrictive ‘medically frail’ definitions.
Why it matters: These policy shifts threaten to dismantle the legal and administrative infrastructure that has protected autistic students’ rights to education and community integration for decades.
Context: The proposed restructuring follows a pattern of executive branch efforts to reduce the Department of Education’s role, while the DOJ memo signals a potential retreat from enforcing Olmstead’s integration mandate.
"The Autism Society of America is concerned that moving IDEA functions to HHS would shift education and transition programs into an agency primarily focused on health and human services. This could fragment the education-to-employment pipeline and weaken coordination among schools, postsecondary education, vocational rehabilitation, and workforce development systems." — AUTISMSOCIETY
Commentary: The fragmentation risk is acute: splitting IDEA from education policy and civil rights enforcement from OCR creates jurisdictional gaps that families will navigate alone. The DOJ memo, while not legally binding, provides cover for states to resist community-based placements, potentially increasing institutionalization. The Medicaid work requirements lawsuit, if unsuccessful, could strip coverage from autistic adults who cannot meet 80-hour monthly thresholds. These three developments collectively represent the most significant federal retrenchment in disability rights enforcement since the ADA’s passage.
Date: July 15, 2026 02:15 PM ET
URL: https://autismsociety.org/capitol-connection-july-15-2026
AI Sentiment Score: Negative (50%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.What does “medically frail” mean? Why does it matter for people who get health care through Medicaid? (Autisticadvocacy)
Summary: A new CMS rule redefines ‘medically frail’ for Medicaid work requirements, requiring individuals to both have a qualifying disability or serious health condition and suggest they cannot work. The rule provides vague examples of qualifying conditions—including SSA-defined disability, ADL impairment, substance use disorders, disabling mental disorders, and serious medical conditions—but offers no clear process for proving inability to work. States are left to determine how to assess work capacity, risking loss of coverage for millions who cannot navigate undefined paperwork. The rule also narrows the definition of ‘serious or complex medical condition’ by excluding people whose treatment keeps them stable, potentially stripping life-sustaining care from those who depend on it.
Why it matters: This rule threatens to disenroll millions of disabled and chronically ill Medicaid recipients by imposing unworkable proof requirements, directly undermining access to life-sustaining treatment for neurodivergent and other disabled populations.
Context: The CMS rule follows a broader push for Medicaid work requirements under previous administrations, but this version introduces a narrower, more punitive definition of medical frailty that could exclude people with well-managed conditions.
"The CMS rule says you also need to prove you can’t work. We still don’t know how people will prove they can’t work. This is part of why this rule is so bad." — AUTISTICADVOCACY
Commentary: The rule’s ambiguity on proof of work incapacity is a feature, not a bug—it offloads administrative burden onto states and individuals, creating a de facto barrier that will reduce Medicaid rolls without explicit disallowance. For autistic and AuDHD individuals, many of whom have co-occurring conditions or executive function challenges, the undefined paperwork requirements will disproportionately cause coverage loss. The narrowing of ‘serious or complex medical condition’ to exclude treatment-stabilized patients is particularly dangerous, as it penalizes effective care. Expect legal challenges from disability rights organizations, but the rule’s implementation timeline may cause real harm before courts intervene.
Date: July 13, 2026 12:40 PM ET
URL: https://autisticadvocacy.org/2026/07/medically-frail/
AI Sentiment Score: Negative (80%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.Post ID: 4ecae5b6